Skip to content

An Exploratory Investigation of a Supplement to Support Student Learning

An Exploratory Investigation of a Supplement to Support Student Learning

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05528094
Enrollment
38
Registered
2022-09-06
Start date
2022-04-14
Completion date
2022-12-15
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concentration Ability Impaired, Mental Fatigue

Brief summary

In this trial, the herbal supplement (GeniusDrops) will be tested to see the effects it has on the dependent variables of interest. Participants will take the supplement twice a day for a month and respond to surveys at study baseline, midpoint, and the conclusion of the study. The findings of this study will be used for marketing materials and to inform future trials using the supplement.

Interventions

DIETARY_SUPPLEMENTGeniusDrops

The active ingredients listed below are safe and the study sponsor has noted there are no known side effects of the supplement. The main ingredients are: Hibiscus flower- Has been shown to boost oxygenation to the brain and vital organs. Has also demonstrated efficacy for boosting the immune system. Gingko leaf- Has been shown to stimulate memory by increasing mental sharpness and clarity. Rhodiola- Helps regulate energy and stress level. Gotu kola- Has been shown to have impacts on reducing anxiety. Licorice Root- Helps boost the key brain neurotransmitter called Brain Derived Neurotrophic factor which can help with cognitive development Peppermint Leaf- Reduces fatigue while helping improve cognitive abilities. Has also been shown to promote immune system function.

Sponsors

Citruslabs
CollaboratorINDUSTRY
JoySpring
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Provision of signed and dated informed consent form and a parental assent form * Must be experiencing issues with focus, mood, and memory * Must be looking to improve classroom performance * Gets easily distracted

Exclusion criteria

* Diagnosis of ADD or ADHD * Currently taking a prescription medication meant to treat ADD or ADHD * Diagnosed with additional conditions that would not allow them to adhere to the protocol. * Willing to take a supplement targeting improving mood, concentration, and focus

Design outcomes

Primary

MeasureTime frameDescription
Examination of self-reported focus4 weeksParticipants will respond to a survey to assess perceived changes in focus.
Examination of Self-reported concentration4 weeksParticipants will respond to a survey to assess perceived changes in concentration
Examination of Self-reported mood states4 weeksParticipants will respond to a survey to assess perceived changes in moods.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026